Skip to content
10-Q

Quarterly Report

SCIVANTA MEDICAL CORP

0001493152-16-013281

← back to feed
Filed
Sep 13, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2016 · Sep 9, 2016 20.93M sh
Operating Cash Flow Q3 2016 · Jul 31, 2016 −$43.51K
Operating Cash Flow Q3 2016 · Jul 31, 2015 −$62.58K
Cash And Equivalents Q3 2016 · Jul 31, 2016 $28.15K
Cash And Equivalents Q3 2016 · Oct 31, 2015 $21.66K
Cash And Equivalents Q3 2016 · Jul 31, 2015 $13.53K
Cash And Equivalents Q3 2016 · Oct 31, 2014 $26.11K
Stockholders Equity Q3 2016 · Jul 31, 2016 −$397.08K
Stockholders Equity Q3 2016 · Oct 31, 2015 −$1.36M
Current Liabilities Q3 2016 · Jul 31, 2016 $429.97K
Current Liabilities Q3 2016 · Oct 31, 2015 $1.29M
Total Liabilities Q3 2016 · Jul 31, 2016 $429.97K
Total Liabilities Q3 2016 · Oct 31, 2015 $1.39M
Current Assets Q3 2016 · Jul 31, 2016 $32.89K
Current Assets Q3 2016 · Oct 31, 2015 $28.63K
Sga Expense Q3 2016 · Jul 31, 2016 $64.84K
Sga Expense Q3 2016 · Jul 31, 2016 $215.97K
Sga Expense Q3 2016 · Jul 31, 2015 $62.83K
Sga Expense Q3 2016 · Jul 31, 2015 $176.98K
Net Income Q3 2016 · Jul 31, 2016 −$69.38K
Net Income Q3 2016 · Jul 31, 2016 −$200.87K
Net Income Q3 2016 · Jul 31, 2015 −$79.75K
Net Income Q3 2016 · Jul 31, 2015 −$231.32K
Operating Income Q3 2016 · Jul 31, 2016 −$64.84K
Operating Income Q3 2016 · Jul 31, 2016 −$110.97K
Operating Income Q3 2016 · Jul 31, 2015 −$62.83K
Operating Income Q3 2016 · Jul 31, 2015 −$176.98K